YouTube2Text

A Small Cap Stock in Super Investor Portfolios 😎| Acutaas Chemicals — Transcript

by SOIC · 563 words · 42 segments · language en · Watch on YouTube

Full transcript

  1. 0:04Today, we'll cover a Pharmaceutical Business—
  2. 0:30Whenever studying the Pharma industry we can divide the value chain in diff. parts (On Screen)
  3. 1:57Some formulation Co.s are virtually integrated i.e backward integrated in APIs.
  4. 2:05We can break this Value Chain down further geographically & product wise.
  5. 2:22Generic mfr. - any medical product that becomes generic - no patent.
  6. 2:38No patent i.e Anyone in the world can mfg. it.
  7. 4:18Today we'll analyse AMI Organics (On Screen)
  8. 5:03Eg. of Co.s in formulation - Sun Pharma.
  9. 6:00Ideally RoCE is highest in Domestic Pharma Co.s but growth trajectory can halt after high penetration.
  10. 10:14They're making interesting chemicals in Speciality. Margin profile is > Pharma Intermediates.
  11. 12:41We'll discuss both their biz. separately. We'll start with Pharma Intermediates (On Screen)
  12. 15:32They make drugs for Co.s discovering molecules.
  13. 15:43Even though it's a 5% Sales— Co.s see 25-30% margins at times.
  14. 15:57They got 3 molecules prev., after the new plant in Ankleshwar they received 2 more.
  15. 16:39We'll see the molecules they're key Mkt. leaders in Pharma Intermediates biz.
  16. 17:52Not narrating names of molecules to avoid complexity. ~20-30% of biz. are in a stable base i.e 5-10% stable growth.
  17. 18:11Apixaban is a molecule that was granted patent which recently expired.
  18. 18:15Ami Organics is one of the only Co. that can make its intermediates. Apixaban is gradually being launched in Europe.
  19. 18:25This is one of the key Molecules to keep an eye on. Today it's not reflected much in the market sales but —.
  20. 18:32This is broadly how their Pharma Intermediate’s biz. looks like.
  21. 18:35Under growth triggers we’ll discuss —, whether it be a Fermion or Apixaban deal to get interesting insights. (On Screen)
  22. 19:01Ami Organics has a huge customer base & having <175 - 180 customers means almost serving the entire ind.
  23. 19:24Pharma Ind. supply their resources to the API players & API is currently being dumped from China.
  24. 19:31The evaporating profitability of API players also impacts Ami Organics. (On Screen)
  25. 20:03A detailed Analysis of Chemical biz. (On Screen)
  26. 21:38The Acquisition of Gujarat organics by Ami Organics was done some time back.
  27. 23:16Even though they’re mfg. Electrolyte additives, the final mfg. process is managed via a CDMO type arrangement.
  28. 23:37This biz is starting from FY25 (On Screen)
  29. 23:40Ami Organics is one of these 4 Indian Co. currently working under EV chemicals. (On Screen)
  30. 25:55So far we discussed the Pharma Intermediate & Chemical biz of Ami Organics. Now we’ll move to Growth Triggers, Risks & Valuations (On Screen)
  31. 28:02Antithesis pointers (On Screen)
  32. 28:22One of the key risk factors- sudden normalisation & expansion of margins, —.
  33. 28:33The TTM PE Multiple of this biz tells that it will see growth as we saw in “Growth Triggers” that the Co. has the potential for Growth.
  34. 28:41In case there’s no Growth, the TTM PE Multiple at 60 seems a bit elevated.
  35. 28:462nd key risk can be Valuation risk which you can individually analyze & assess.
  36. 29:13Despite claiming high margins in the Concalls, —.
  37. 29:24As seen in the announcements: several Chemical Co. have been installing battery complexes for their Electrolytes & Additives.
  38. 34:52Today the Co. Market Cap is at INR 3947 Cr.
  39. 34:56Today the Co is nearly 2 yrs forward with 40x earnings.
  40. 35:03If the margins ↑, for instance by 24% this margin could ↑.
  41. 35:15We always forecast and try to be as conservative as possible.
  42. 35:20Hopefully you’ve understood how Forecasting of Co. can done through P&L (On Screen)

About this transcript

This page contains the full transcript of A Small Cap Stock in Super Investor Portfolios 😎| Acutaas Chemicals by SOIC, generated from the public captions YouTube serves with the video. The transcript has 563 words across 42 segments, with the original timestamps preserved so you can click any line to jump to that moment in the embedded player.

What you can do with it

Use the transcript to take notes, quote the speaker, build a study guide, generate a summary with ChatGPT or Claude via the YouTube Summary tool, or export it as a timed subtitle file with YouTube to SRT. You can also re-open it in the transcriber to choose a caption track available on the video.

Free YouTube transcript tool

YouTube2Text is a free YouTube transcript generator — no signup, no daily limit. Paste any YouTube link and get the full transcript instantly, with timestamps, click-to-jump, caption language selection, AI prompts for ChatGPT, Claude, and Gemini, and exports to TXT, SRT, VTT, or Markdown.